ProShare Advisors LLC Acquires New Holdings in Astera Labs, Inc. $ALAB

ProShare Advisors LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 11,949 shares of the company’s stock, valued at approximately $2,340,000.

Several other large investors have also recently bought and sold shares of ALAB. Whittier Trust Co. purchased a new position in shares of Astera Labs during the 3rd quarter valued at $55,000. Atlantic Union Bankshares Corp grew its position in Astera Labs by 1,338.1% during the third quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock worth $59,000 after buying an additional 281 shares in the last quarter. Grove Bank & Trust bought a new position in Astera Labs in the 3rd quarter worth about $68,000. Cullen Frost Bankers Inc. increased its stake in Astera Labs by 1,560.0% in the 3rd quarter. Cullen Frost Bankers Inc. now owns 415 shares of the company’s stock worth $81,000 after acquiring an additional 390 shares during the last quarter. Finally, Clearstead Trust LLC raised its holdings in shares of Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after acquiring an additional 461 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ALAB has been the subject of several recent analyst reports. Needham & Company LLC boosted their price objective on Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Royal Bank Of Canada began coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Barclays set a $165.00 price objective on shares of Astera Labs in a report on Thursday, January 15th. Finally, JPMorgan Chase & Co. increased their target price on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Fourteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $192.89.

Astera Labs Stock Performance

Shares of ALAB opened at $129.32 on Friday. The firm has a market cap of $21.84 billion, a price-to-earnings ratio of 106.00, a PEG ratio of 2.80 and a beta of 1.50. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The firm has a 50 day moving average price of $164.09 and a 200-day moving average price of $174.51.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Insider Activity

In other news, CFO Michael Truett Tate sold 11,430 shares of Astera Labs stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the transaction, the chief financial officer owned 192,297 shares in the company, valued at approximately $27,823,452.93. The trade was a 5.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 90,459 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. This represents a 5.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 576,936 shares of company stock valued at $87,409,540. Company insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.